Clinical Trials Logo

Clinical Trial Summary

The present study is designed to investigate the short-term and long-term renoprotective role of pneumoperitoneum preconditioning in patients undergoing laparoscopic partial nephrectomy.


Clinical Trial Description

Renal ischemia reperfusion injury (IRI) is an inevitable event in patients undergoing laparoscopic partial nephrectomy (LPN), which can obviously affect the post-operational renal function. Pneumoperitoneum preconditioning (PP) is a promising strategy to render a protective effect on kidney, which has been already confirmed in some clinical settings. This study is designed as a randomized, prospective, double-blind and parallel controlled clinical trial to assess the short-term and long-term renoprotective role of pneumoperitoneum preconditioning in patients undergoing laparoscopic partial nephrectomy, and observe its effect on the other abdominal organs. Patients with renal tunours and willing to accept elective LPN will be screened as eligible participants. The investigators aim to enroll 86 subjects. Patients randomized to the treatment arm will receive PP consisted of three cycles of 5 min insufflation and 5 min desufflation before PLN, while the control arm receive a sham operation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03822338
Study type Interventional
Source Nanjing First Hospital, Nanjing Medical University
Contact Ruipeng Jia, MD, PHD
Phone +86-02552271061
Email urojiarp@njmu.edu.cn
Status Recruiting
Phase N/A
Start date January 1, 2021
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06369350 - Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion Early Phase 1
Withdrawn NCT04388761 - Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI) Phase 1
Completed NCT00987974 - Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury Phase 4
Recruiting NCT04750616 - NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial Phase 2
Recruiting NCT05992259 - Auricular Vagus Stimulation and STEMI N/A
Completed NCT04493983 - Role of Oxidative Stress in Ovarian Tissue After CO2-pneumoperitoneum Application-induced I/R N/A
Completed NCT03510793 - Microcirculation and Anesthesia in Vascular Surgery
Recruiting NCT02845154 - Intermittent Portal and Graft Purge in Living Donor Liver Transplantation N/A
Terminated NCT01564095 - TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion Phase 2/Phase 3
Completed NCT03482544 - The Effect of Pregabalin Given Preoperatively on the Tourniquet Induced Ischemia-reperfusion Phase 4
Not yet recruiting NCT05004610 - Hypertonic Lactate After Cardiac Arrest Phase 2
Completed NCT04205253 - Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue
Completed NCT03410576 - Perioperative Time Course of MMP-9 and Its Inhibitor During Carotid Artery Stenting and Carotid Endarterectomy N/A
Completed NCT03743584 - Hypothermia After Cardiac Arrest - Effects on Myocardial Function and Inflammatory Response. N/A
Recruiting NCT04005469 - Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation Phase 1/Phase 2
Recruiting NCT04630535 - OSA as a Remote Ischemic Preconditioning in Vascular Surgery
Completed NCT01610401 - The Metformin-FMD Trial Phase 4
Active, not recruiting NCT00876902 - YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation Phase 2
Completed NCT03541239 - Immune Modulation by Ischemic Pre-conditioning in Healthy Individuals: Intracellular Signalling in Regulatory Cells N/A
Recruiting NCT05430620 - Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys Phase 3